GlassScriptPhysician profile
Judy Kang
NPI 1093716300
$16,253.39
in general payments reported to CMS, 2019-2025
45 companies · $3,623 in 2025
The $3,623 reported for 2025 was more than what 85% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,094 · 2020: $1,040 · 2021: $1,841 · 2022: $2,155 · 2023: $3,000 · 2024: $2,500 · 2025: $3,623.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,123.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,122.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $4,772.56 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $3,612.31 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $941.58 | 2019-2025 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Genzyme Corporation | $808.45 | 2019-2025 | |
| Grifols USA, LLC | $728.16 | 2019-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $651.86 | 2019-2025 | Dupixent |
| Baxter Healthcare | $535.48 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Actelion Pharmaceuticals US, INC. | $518.35 | 2022-2025 | Uptravi, Opsumit, Opsynvi |
| Mylan Specialty L.P. | $379.03 | 2019-2024 | Yupelri |
| Viatris Specialty LLC | $345.64 | 2025 | Yupelri |
| Verona Pharma, INC. | $319.06 | 2025 | Ohtuvayre |
| Insmed, INC. | $227.20 | 2019-2025 | Arikayce, Brinsupri |
| Genentech USA, INC. | $226.40 | 2019-2022 | |
| Electromed, INC. | $212.16 | 2022-2025 | Smartvest |
| Ani Pharmaceuticals, INC. | $185.91 | 2024-2025 | Purified Cortrophin Gel |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Kang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.